Zacharon Pharmaceuticals' Series A Round

Zacharon Pharmaceuticals raised a round of funding on November 25, 2008. Investors include Avalon Ventures.

Zacharon Pharmaceuticals is leveraging glycobiology expertise to develop a new class of human therapeutics targeting glycans, the carbohydrate portions of glycoproteins, proteoglycans, and glycolipids…

Articles about Zacharon Pharmaceuticals' Series A Round: